in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (1 week ago)
Towards Semantic Interoperability of Publicly Available Data https://t.co/YIv7avHvns
Douglas Connect (4 weeks ago)
A couple of places are still available for the eChemInfo workshop in Milano starting July 17. Register now at https://t.co/NxBAmGIFtz.
Douglas Connect (4 weeks ago)
RT @barryhardy: Your OpenTox newsletter is here! https://t.co/YVaUuCIe2G https://t.co/41xKSQSVQn
Douglas Connect (5 weeks ago)
Find out details on the new e-Infrastructure supporting #knowledgesharing in risk assessment at https://t.co/WTnwSNUnRU #OpenRiskNet #H2020
Douglas Connect (6 weeks ago)
Integrated testing strategy (ITS) for Skin Sensitisation. Skin Sens ITS predictor https://t.co/OK2cryVLmb More info https://t.co/94plUrof3G

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com